In the SWI/SNF-mutant cohort, a seven-gene signature comprising CRIM1 (angiogenesis), VEGFC (lymphangiogenesis), BMP7 (tumor microenvironment regulation), NR1D2 (immune modulation), BMPR1B (tumor proliferation), CR2 (B-cell activation), and TAPBPL (antigen presentation) was ultimately retained. The gene discussed is CR2; the disease is neoplasm.